glucagon-like peptide 1 for diabetes mellitus (Mapi Pharma)

N/A

Report date: 2025/01/26 18:00:57

Base Information

Drug Nameglucagon-like peptide 1 for diabetes mellitus (Mapi Pharma)
Drug Alias NameGLP-1 Depot (Mapi Pharma)GLP-1 Depot (Mapi Pharma)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionGlucagon-like peptide 1 receptor agonists
TargetsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsBody Weight ChangesDiabetes MellitusAlzheimer Disease +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMapi Pharma Ltd
China Registration ClassN/A

Develop Information

Active CompaniesMapi Pharma Ltd
Inactive CompaniesN/A
Active IndicationsBody Weight ChangesDiabetes MellitusAlzheimer Disease +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A